Tango Therapeutics, Inc. (TNGX) Free cash flow 2020–2025
Tango Therapeutics, Inc. (TNGX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$139.9MFY2025 · since FY2020: $69.0M → -$139.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$139.9M | -5.8% |
| FY2024 | -$132.3M | -10.7% |
| FY2023 | -$119.5M | -2.3% |
| FY2022 | -$116.8M | -90.3% |
| FY2021 | -$61.4M | -189.0% |
| FY2020 | $69.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice